Compound details
Cis-zeatin-7-N-glucoside
| Compound ID | CDAMM00502 |
|---|---|
| Common name | Cis-zeatin-7-N-glucoside | IUPAC name | 2-(hydroxymethyl)-6-[6-[(4-hydroxy-3-methylbut-2-enyl)amino]purin-7-yl]oxane-3,4,5-triol |
| Molecular formula | C16H23N5O6 |
| Retention time | 11 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 382.173 | Theoretical mz | 382.172 |
| Error | 1.11 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 8.3178 |
| Inchi key | HTDHRCLVWUEXIS-HNVSNYHQSA-N |
|---|---|
| Smiles | OCC(=CCNC1=NC=NC=2N=CN(C21)C3OC(CO)C(O)C(O)C3O)C |
| Superclass | Organic oxygen compounds |
| Class | Organooxygen compounds |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction and SEA |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction and SEA |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction and SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P10253 | GAA | Lysosomal alpha-glucosidase (by homology) | T31514 | SwissTargetPrediction |
| P13866 | SLC5A1 | Sodium/glucose cotransporter 1 | T54771 | SwissTargetPrediction |
| P08473 | MME | Neprilysin | T05409 | SwissTargetPrediction |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SwissTargetPrediction |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction |
| P29275 | ADORA2B | Adenosine A2b receptor | T86679 | SwissTargetPrediction and SEA |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P04183 | TK1 | Thymidine kinase, cytosolic | T30081 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SwissTargetPrediction |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| Q13547 | HDAC1 | Histone deacetylase 1 | T68547 | SwissTargetPrediction |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P78536 | ADAM17 | ADAM17 | T82393 | SwissTargetPrediction |
| P09237 | MMP7 | Matrix metalloproteinase 7 | T73475 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P26358 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 (by homology) | T88304 | SEA |
| P32320 | CDA | Cytidine deaminase (by homology) | T79027 | SEA |
| P00813 | ADA | Adenosine deaminase | T03661 | SwissTargetPrediction and SEA |
| P04062 | GBA | Beta-glucocerebrosidase | T84173 | SwissTargetPrediction |
| P55263 | ADK | Adenosine kinase | T91661 | SwissTargetPrediction and SEA |
| O60502 | OGA | Bifunctional protein NCOAT | T19567 | SwissTargetPrediction |
| P11142 | HSPA8 | Heat shock cognate 71 kDa protein | T12817 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase liver | T39321 | SwissTargetPrediction and SEA |
| Q99808 | SLC29A1 | Equilibrative nucleoside transporter 1 | T13491 | SwissTargetPrediction and SEA |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction |
| P52789 | HK2 | Hexokinase type II | T96685 | SwissTargetPrediction |
| P11021 | HSPA5 | 78 kDa glucose-regulated protein | T77594 | SwissTargetPrediction |
| O43868 | SLC28A2 | Sodium/nucleoside cotransporter 2 | T94627 | SEA |
| P39900 | MMP12 | Matrix metalloproteinase 12 | T03500 | SwissTargetPrediction |
| P23526 | AHCY | Adenosylhomocysteinase | T68698 | SwissTargetPrediction and SEA |
| Q9NY91 | SLC5A4 | Low affinity sodium-glucose cotransporter | T22583 | SwissTargetPrediction |
| P31639 | SLC5A2 | Sodium/glucose cotransporter 2 | T30085 | SwissTargetPrediction |
| P01112 | HRAS | Transforming protein p21/H-Ras-1 | T71081 | SwissTargetPrediction |
| P17931 | LGALS3 | Galectin-3 | T72038 | SwissTargetPrediction |
| P14679 | TYR | Tyrosinase | T97035 | SwissTargetPrediction |
| Q8TEK3 | DOT1L | Histone-lysine N-methyltransferase, H3 lysine-79 specific | T87686 | SEA |
| P55786 | NPEPPS | Puromycin-sensitive aminopeptidase | T15610 | SEA |
| P47900 | P2RY1 | Purinergic receptor P2Y1 | T67818 | SEA |
| P41231 | P2RY2 | Purinergic receptor P2Y2 | T93515 | SEA |
| Q99873 | PRMT1 | Protein-arginine N-methyltransferase 1 | T16808 | SEA |
| Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | T53251 | SEA |
| P16885 | PLCG2 | Phospholipase C-gamma-2 | T93922 | SEA |
| Q9H9B1 | EHMT1 | Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 | T39996 | SEA |
| Q9UBC3 | DNMT3B | DNA (cytosine-5)-methyltransferase 3B | T65501 | SEA |
| P51575 | P2RX1 | P2X purinoceptor 1 | T69091 | SEA |
| P17707 | AMD1 | S-adenosylmethionine decarboxylase 1 | T55922 | SEA |
| Q8WTS6 | SETD7 | Histone-lysine N-methyltransferase SETD7 | T73184 | SwissTargetPrediction and SEA |
| Q9NVM4 | PRMT7 | Protein arginine N-methyltransferase 7 | T79501 | SEA |
| O43463 | SUV39H1 | Histone-lysine N-methyltransferase SUV39H1 | T39519 | SEA |
| Q92800 | EZH1 | Histone-lysine N-methyltransferase EZH1 | T17986 | SEA |
| Q99571 | P2RX4 | P2X purinoceptor 4 | T60330 | SEA |
| Q13304 | GPR17 | Uracil nucleotide/cysteinyl leukotriene receptor | T33902 | SEA |
| Q86Y97 | KMT5C | Histone-lysine N-methyltransferase KMT5C | T68490 | SEA |
| Q9NZ70 | TAK1 | TGF-beta-activated kinase 1 | T04361 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T31514 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | P10253 | GAA |
| T54771 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13866 | SLC5A1 |
| T54771 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P13866 | SLC5A1 |
| T54771 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P13866 | SLC5A1 |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T86679 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P29275 | ADORA2B |
| T86679 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P29275 | ADORA2B |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T30081 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P04183 | TK1 |
| T30081 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P04183 | TK1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T68547 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q13547 | HDAC1 |
| T68547 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | Q13547 | HDAC1 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T82393 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P78536 | ADAM17 |
| T82393 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P78536 | ADAM17 |
| T73475 | DI0238 | Lung cancer | [ICD-11: 2C25] | P09237 | MMP7 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T88304 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P26358 | DNMT1 |
| T88304 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P26358 | DNMT1 |
| T88304 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P26358 | DNMT1 |
| T79027 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P32320 | CDA |
| T03661 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P00813 | ADA |
| T03661 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P00813 | ADA |
| T03661 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P00813 | ADA |
| T84173 | DI0257 | Metabolic disorder | [ICD-11: 5C50-5D2Z] | P04062 | GBA |
| T91661 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P55263 | ADK |
| T19567 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O60502 | OGA |
| T19567 | DI0331 | Parkinsonism | [ICD-11: 8A00] | O60502 | OGA |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T39321 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P04406 | GAPDH |
| T39321 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04406 | GAPDH |
| T13491 | DI0030 | Angina pectoris | [ICD-11: BA40] | Q99808 | SLC29A1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T96685 | DI0133 | Epidermal dysplasias | [ICD-11: EK90] | P52789 | HK2 |
| T77594 | DI0252 | Melanoma | [ICD-11: 2C30] | P11021 | HSPA5 |
| T77594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11021 | HSPA5 |
| T03500 | DI0037 | Asthma | [ICD-11: CA23] | P39900 | MMP12 |
| T03500 | DI0238 | Lung cancer | [ICD-11: 2C25] | P39900 | MMP12 |
| T03500 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P39900 | MMP12 |
| T22583 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q9NY91 | SLC5A4 |
| T22583 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q9NY91 | SLC5A4 |
| T30085 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P31639 | SLC5A2 |
| T30085 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P31639 | SLC5A2 |
| T30085 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P31639 | SLC5A2 |
| T72038 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P17931 | LGALS3 |
| T72038 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P17931 | LGALS3 |
| T72038 | DI0252 | Melanoma | [ICD-11: 2C30] | P17931 | LGALS3 |
| T72038 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P17931 | LGALS3 |
| T72038 | DI0351 | Psoriasis | [ICD-11: EA90] | P17931 | LGALS3 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T87686 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q8TEK3 | DOT1L |
| T87686 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q8TEK3 | DOT1L |
| T87686 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q8TEK3 | DOT1L |
| T15610 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P55786 | NPEPPS |
| T15610 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P55786 | NPEPPS |
| T93515 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P41231 | P2RY2 |
| T16808 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99873 | PRMT1 |
| T53251 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q96KQ7 | EHMT2 |
| T53251 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q96KQ7 | EHMT2 |
| T53251 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96KQ7 | EHMT2 |
| T39996 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9H9B1 | EHMT1 |
| T39996 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H9B1 | EHMT1 |
| T65501 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBC3 | DNMT3B |
| T55922 | DI0004 | Acidosis | [ICD-11: 5C73] | P17707 | AMD1 |
| T73184 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q8WTS6 | SETD7 |
| T17986 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q92800 | EZH1 |
| T17986 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q92800 | EZH1 |
| T17986 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q92800 | EZH1 |
| T17986 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q92800 | EZH1 |
| T17986 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | Q92800 | EZH1 |
| T17986 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | Q92800 | EZH1 |
| T17986 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92800 | EZH1 |
| T17986 | DI0423 | Ureteral cancer | [ICD-11: 2C92] | Q92800 | EZH1 |
| T04361 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q9NZ70 | TAK1 |